Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Tetraspanin CD9 Is Involved in Primary Myelofibrosis Dysmegakaryopoiesis Through c-Myb Regulation and Stroma Interactions,

Christophe Desterke, PhD, Costanza Bogani, PhD, Lisa Pieri, MD, Alessandro M. Vannucchi, MD, PhD, Bernadette Guerton, Christophe Martinaud, MD, Denis Clay, Jean-Jacques Lataillade, MD, PhD, Hans Hasselbalch, MD, PhD, Heinz Gisslinger, MD, PhD, Sophie Amsellem, PhD, Jean-Loup Demory, MD, Agnès Charpentier, MD, Brigitte Dupriez, Claude Boucheix, MD, PhD, Eric Rubinstein, PhD, Marie-Caroline Le Bousse-Kerdiles, PhD

Blood (2011) 118 (21): 3834.

https://doi.org/10.1182/blood.V118.21.3834.3834

Published: 2011

Journal Articles

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Agnès Charpentier, MD, Stéphanie Devaux, Judith Bruge-Debreu, MD, Nathalie Cambier, MD, Christian Rose, MD, PhD, Jean-Loup Demory, MD

Blood (2011) 118 (21): 5166.

https://doi.org/10.1182/blood.V118.21.5166.5166

Published: 2011

Journal Articles

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Véronique Tintillier-Colin, Nathalie Cambier, MD, Emmanuelle Bourgeois-Petit, MD, Christian Rose, MD, Gérard Forzy, MD, Jean-Loup Demory, MD, Agnès Charpentier, MD

Blood (2009) 114 (22): 1906.

https://doi.org/10.1182/blood.V114.22.1906.1906

Published: 2009

Journal Articles

Expression of HMGA2 in PB Leukocytes and Purified CD34+ Cells from Normal Individuals and Patients with Myelofibrosis and Myeloid Metaplasia.

Joris R. Andrieux, MD, PhD, Chrystèle Bilhou-Nabera, MD, Jean Loup Demory, MD, Olivier Pierre-Louis, Brigitte Dupriez, MD, Nathalie Grardel, MD, Agnès Charpentier, MD, Vincent Praloran, MD, Francis Bauters, MD, Jean Luc Laï, PhD, Marie-Caroline Le Bousse-Kerdilès, PhD

Blood (2004) 104 (11): 2435.

https://doi.org/10.1182/blood.V104.11.2435.2435

Published: 2004

Journal Articles

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Chrystèle Bilhou-Nabera, MD, PhD, Joris R. Andrieux, MD, PhD, Olivier Pierre-Louis, Marie-Caroline Le Bousse-Kerdilès, PhD, Brigitte Dupriez, MD, Nathalie Grardel, MD, Agnès Charpentier, MD, Vincent Praloran, MD, Francis Bauters, MD, Jean Luc Laï, PhD, Jean Loup Demory, MD

Blood (2004) 104 (11): 2436.

https://doi.org/10.1182/blood.V104.11.2436.2436

Published: 2004

NARROW

The Tetraspanin CD9 Is Involved in Primary Myelofibrosis Dysmegakaryopoiesis Through c-Myb Regulation and Stroma Interactions,

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Expression of HMGA2 in PB Leukocytes and Purified CD34+ Cells from Normal Individuals and Patients with Myelofibrosis and Myeloid Metaplasia.

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Email alerts

ASH Publications

American Society of Hematology

The Tetraspanin CD9 Is Involved in Primary Myelofibrosis Dysmegakaryopoiesis Through c-Myb Regulation and Stroma Interactions,

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Expression of HMGA2 in PB Leukocytes and Purified CD34+ Cells from Normal Individuals and Patients with Myelofibrosis and Myeloid Metaplasia.

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only